Analyst Ratings For NASDAQ:SPHS – Sophiris Bio (NASDAQ:SPHS)
Today, Maxim Group raised its price target on NASDAQ:SPHS – Sophiris Bio (NASDAQ:SPHS) to per share.
Some recent analyst ratings include
- 6/1/2017-Rodman & Renshaw Reiterated Rating of Buy.
- 4/6/2017-Piper Jaffray Reiterated Rating of Overweight.
- 11/11/2016-Roth Capital Reiterated Rating of Buy.
- 6/10/2016-Echelon Wealth Partners Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:SPHS – Sophiris Bio (NASDAQ:SPHS)
NASDAQ:SPHS – Sophiris Bio (NASDAQ:SPHS) has insider ownership of 3.90% and institutional ownership of 6.43%.
- On 12/15/2014 Boxer Capital, Llc, Major Shareholder, sold 881,479 with an average share price of $0.61 per share and the total transaction amounting to $537,702.19.
- On 11/14/2014 Randall E Woods, Insider, bought 3,000 with an average share price of $2.43 per share and the total transaction amounting to $7,290.00.
- On 9/19/2014 Gerald T Proehl, Director, bought 10,000 with an average share price of $3.16 per share and the total transaction amounting to $31,600.00.
- On 7/10/2014 Randall E Woods, Insider, bought 1,000 with an average share price of $2.65 per share and the total transaction amounting to $2,650.00.
- On 7/9/2014 Randall E Woods, Insider, bought 1,000 with an average share price of $2.66 per share and the total transaction amounting to $2,660.00.
- On 6/6/2014 James L Heppell, Director, sold 19,231 with an average share price of $2.59 per share and the total transaction amounting to $49,808.29.
- On 8/22/2013 Randall E Woods, CEO, bought 2,500 with an average share price of $4.50 per share and the total transaction amounting to $11,250.00.
Recent Trading Activity for NASDAQ:SPHS – Sophiris Bio (NASDAQ:SPHS)
Shares of NASDAQ:SPHS – Sophiris Bio closed the previous trading session at 3.26 up +0.17 5.50% with 3.190000057220459 shares trading hands.